Clinical features and biomarkers that can be used to differentiate between non-T2 and T2-high asthma have been proposed, including an IgE threshold of 100 IU/mL and reactivity of both skin prick test (SPT) and radioallergosorbent test (RAST) (13). The gene discussed is IGHE; the disease is asthma.